Hydroxychloroquine Reduces Mortality by 35% in Hospitalized COVID-19 Patients
This study from Belgium demonstrates that the use of standard/low dose hydroxychloroquine and azithromycin (macrolide) in hospitalized COVID-19 patients reduces the risk of mortality by 35%. Let’s review.